Directive (EU) 2022/642 of the European Parliament and of the Council of 12 April 2022 amending Directives 2001/20/EC and 2001/83/EC as regards derogations from certain obligations concerning certain medicinal products for human use made available in the United Kingdom in respect of Northern Ireland and in Cyprus, Ireland and Malta (Text with EEA relevance)
Basic information
Dates Date of document:
  • April 12, 2022
Date of publication:
  • April 20, 2022
Date of effect:
  • April 20, 2022
    • Entry into force - Date pub. See Art 4
Date of transposition:
  • January 1, 2022
    • Application See Art 3.1
  • August 20, 2022
    • Adoption See Art 3.1
Modified by
Modifies
Modifies:
Affected by case
Legal basis
  • Consolidated version of the Treaty on the Functioning of the European Union PART THREE - UNION POLICIES AND INTERNAL ACTIONS TITLE VII - COMMON RULES ON COMPETITION, TAXATION AND APPROXIMATION OF LAWS CHAPTER 3 - APPROXIMATION OF LAWS Article 114 (ex Article 95 TEC)
EuroVoc Vocabulary
  • Clinical trial
  • Health protection
  • Medicinal product
  • Import
  • Proprietary medicinal products
  • Ireland
  • Malta
  • Approximation of laws
  • United Kingdom
  • Security of supply
  • Public health
  • Northern Ireland
  • Internal market - Principles
  • Cyprus
  • Medicinal products
  • Market approval
  • Import licence